Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Todd Verdoorn0
Rick Pauls0
Date of Patent
January 2, 2024
0Patent Application Number
164920590
Date Filed
March 9, 2018
0Patent Citations
...
Patent Primary Examiner
Patent abstract
Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 μg/kg to about 10.0 μg/kg, including subcutaneous and intravenous dosage forms. Also provided are related devices and methods of use thereof, for example, for treating ischemic and hemorrhagic conditions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.